33 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Clearside Biomedical, Inc. CLSD stock increased by 10.8% to $0.88 during Wednesday's pre-market session. The market cap seems to be at $26.0 million.
  • Hanger, Inc. HNGR shares increased by 9.7% to $22.58. The market cap stands at $781.1 million.
  • Guardion Health Sciences, Inc. GHSI stock moved upwards by 9.6% to $0.55. The market cap seems to be at $28.3 million.
  • Boston Scientific, Inc. BSX shares moved upwards by 6.0% to $40.50. The market cap seems to be at $56.6 billion. The most recent rating by Raymond James, on October 14, is at Strong Buy, with a price target of $48.00.
  • BioNTech, Inc. BNTX shares surged 5.1% to $21.70.
  • Melinta Therapeutics, Inc. MLNT shares increased by 4.7% to $5.09. The market cap seems to be at $48.6 million. According to the most recent rating by H.C. Wainwright, on August 12, the current rating is at Neutral.
  • Titan Pharmaceuticals, Inc. TTNP stock moved upwards by 4.6% to $0.19. The market cap seems to be at $4.2 million. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
  • Tonix Pharmaceuticals, Inc. TNXP shares moved upwards by 4.0% to $0.41. The market cap seems to be at $6.0 million.
  • SELLAS Life Sciences, Inc. SLS stock moved upwards by 3.7% to $0.13. The market cap seems to be at $27.4 million.
  • Plus Therapeutics, Inc. PSTV shares rose 3.6% to $2.85. The market value of their outstanding shares is at $1.5 million.
  • vTv Therapeutics, Inc. VTVT shares surged 3.4% to $1.54. The market cap stands at $90.7 million.
  • Paratek Pharmaceuticals, Inc. PRTK stock increased by 3.1% to $3.60. The market cap stands at $155.1 million.
  • Alkermes, Inc. ALKS stock moved upwards by 3.0% to $19.00. The market cap stands at $3.1 billion. The most recent rating by Morgan Stanley, on September 05, is at Equal-Weight, with a price target of $20.00.
  • Bellerophon Therapeutics, Inc. BLPH shares moved upwards by 2.8% to $0.59. The market value of their outstanding shares is at $33.2 million.
  • Verastem Oncology, Inc. VSTM shares moved upwards by 2.6% to $1.16. The market cap seems to be at $89.7 million.
  • Agile Therapeutics, Inc. AGRX shares rose 2.5% to $1.22. The market cap stands at $65.2 million.
  • Biogen, Inc. BIIB stock surged 2.4% to $288.50. The market value of their outstanding shares is at $42.9 billion. According to the most recent rating by Guggenheim, on October 23, the current rating is at Buy.
  • Fresenius Medical Care, Inc. FMS stock moved upwards by 2.2% to $32.91. According to the most recent rating by Redburn, on October 23, the current rating is at Neutral.

 

Losers

  • Midatech Pharma, Inc. MTP shares decreased by 37.4% to $0.87 during Wednesday's pre-market session.
  • Soleno Therapeutics, Inc. SLNO shares plummeted 23.3% to $1.15. The market value of their outstanding shares is at $55.9 million.
  • TrovaGene, Inc. TROV stock fell 11.2% to $1.59. The market value of their outstanding shares is at $9.3 million.
  • OPKO Health, Inc. OPK stock plummeted 7.4% to $1.99. The market value of their outstanding shares is at $1.2 billion.
  • Biolase, Inc. BIOL stock decreased by 7.1% to $0.65. The market cap stands at $20.5 million.
  • Sophiris Bio, Inc. SPHS stock declined 5.7% to $0.50. The market value of their outstanding shares is at $22.0 million.
  • Anthem, Inc. ANTM shares plummeted 3.4% to $251.50. The market cap stands at $63.4 billion. The most recent rating by Mizuho, on October 18, is at Neutral, with a price target of $262.00.
  • Xenetic Biosciences, Inc. XBIO stock declined 3.4% to $1.43. The market value of their outstanding shares is at $6.5 million.
  • Eli Lilly, Inc. LLY stock declined 3.0% to $106.72. The market value of their outstanding shares is at $109.3 billion. The most recent rating by Bank of America, on October 17, is at Buy, with a price target of $133.00.
  • Genmab, Inc. GMAB shares declined 3.0% to $20.68. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
  • VBI Vaccines, Inc. VBIV shares fell 2.5% to $0.55. The market cap seems to be at $83.9 million.
  • OpGen, Inc. OPGN shares decreased by 2.5% to $5.75. The market value of their outstanding shares is at $6.7 million.
  • Conatus Pharmaceuticals, Inc. CNAT stock plummeted 2.5% to $0.33. The market value of their outstanding shares is at $11.2 million.
  • Eton Pharmaceuticals, Inc. ETON shares declined 2.2% to $6.29. The market cap stands at $112.2 million. The most recent rating by H.C. Wainwright, on October 23, is at Buy, with a price target of $21.00.
  • Obalon Therapeutics, Inc. OBLN stock decreased by 2.1% to $1.90. The market value of their outstanding shares is at $11.6 million.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...